68 related articles for article (PubMed ID: 29981869)
1. Hepatitis C virus (HCV) genotype 1 NS5A resistance-associated variants are associated with advanced liver fibrosis independently of HCV-transmission clusters.
Parczewski M; Kordek J; Janczewska E; Pisula A; Łojewski W; Socha Ł; Wawrzynowicz-Syczewska M; Bociąga-Jasik M; Szymczak A; Cielniak I; Siwak E; Mularska E; Aksak-Wąs B; Urbańska A; Lübke N
Clin Microbiol Infect; 2019 Apr; 25(4):513.e1-513.e6. PubMed ID: 29981869
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of naturally occurring NS5A resistance-associated substitutions in patients infected with hepatitis C virus subtype 1a, 1b, and 3a, co-infected or not with HIV in Brazil.
Malta F; Gaspareto KV; Lisboa-Neto G; Carrilho FJ; Mendes-Correa MC; Pinho JRR
BMC Infect Dis; 2017 Nov; 17(1):716. PubMed ID: 29132303
[TBL] [Abstract][Full Text] [Related]
3. Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients.
Dietz J; Susser S; Berkowski C; Perner D; Zeuzem S; Sarrazin C
PLoS One; 2015; 10(8):e0134395. PubMed ID: 26317755
[TBL] [Abstract][Full Text] [Related]
4. Characterization of HCV NS3 Protease Variants in HCV/HIV-Coinfected Patients by Ultra-Deep Sequence Analysis: Relationship with Hepatic Fibrosis.
Abdel-Hameed EA; Rouster SD; Zhang X; Chen J; Medvedovic M; Goodman ZD; Sherman KE
J Acquir Immune Defic Syndr; 2017 Mar; 74(3):353-358. PubMed ID: 27898525
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Screening for Naturally Occurring Hepatitis C Virus Resistance to Direct-Acting Antivirals in the NS3, NS5A, and NS5B Genes in Worldwide Isolates of Viral Genotypes 1 to 6.
Patiño-Galindo JÁ; Salvatierra K; González-Candelas F; López-Labrador FX
Antimicrob Agents Chemother; 2016 Apr; 60(4):2402-16. PubMed ID: 26856832
[TBL] [Abstract][Full Text] [Related]
6. Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845.
Vijgen L; Thys K; Vandebosch A; Van Remoortere P; Verloes R; De Meyer S
Virol J; 2017 May; 14(1):101. PubMed ID: 28569206
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of HCV NS3 pre-treatment resistance associated amino acid variants within a Scottish cohort.
Shepherd SJ; Abdelrahman T; MacLean AR; Thomson EC; Aitken C; Gunson RN
J Clin Virol; 2015 Apr; 65():50-3. PubMed ID: 25766988
[TBL] [Abstract][Full Text] [Related]
8. Naturally Occurring Resistance-Associated Variants to Hepatitis C Virus Direct-Acting Antiviral Agents in Treatment-Naive HCV Genotype 6a-Infected Patients.
Li Z; Liu Y; Zhang Y; Shao X; Luo Q; Guo X; Lin G; Cai Q; Zhao Z; Chong Y
Biomed Res Int; 2017; 2017():9849823. PubMed ID: 29164151
[TBL] [Abstract][Full Text] [Related]
9. NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients.
Bellocchi MC; Aragri M; Carioti L; Fabeni L; Pipitone RM; Brancaccio G; Sorbo MC; Barbaliscia S; Di Maio VC; Bronte F; Grimaudo S; Mazzucco W; Frigeri F; Cantone M; Pinto A; Perno CF; Craxì A; Gaeta GB; Di Marco V; Ceccherini-Silberstein F
Cells; 2019 Jul; 8(7):. PubMed ID: 31269695
[No Abstract] [Full Text] [Related]
10. Hepatitis C Virus Genotype 5 Variability in Treatment-Naïve Patients in South Africa.
Maunye TK; Gededzha MP; Blackard JT; Rakgole JN; Selabe SG
Intervirology; 2023; 66(1):77-87. PubMed ID: 37231989
[TBL] [Abstract][Full Text] [Related]
11. Global prevalence of pre-existing HCV variants resistant to direct-acting antiviral agents (DAAs): mining the GenBank HCV genome data.
Chen ZW; Li H; Ren H; Hu P
Sci Rep; 2016 Feb; 6():20310. PubMed ID: 26842909
[TBL] [Abstract][Full Text] [Related]
12. Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors.
Pham LV; Ramirez S; Carlsen THR; Li YP; Gottwein JM; Bukh J
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348150
[TBL] [Abstract][Full Text] [Related]
13. Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1-6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance.
Cuypers L; Li G; Libin P; Piampongsant S; Vandamme AM; Theys K
Viruses; 2015 Sep; 7(9):5018-39. PubMed ID: 26389941
[TBL] [Abstract][Full Text] [Related]
14. Ser38-His93-Asn91 triad confers resistance of JFH1 HCV NS5A-Y93H variant to NS5A inhibitors.
Lee WP; Tsai KC; Liao SX; Huang YH; Hou MC; Lan KH
FEBS J; 2024 Mar; 291(6):1264-1274. PubMed ID: 38116713
[TBL] [Abstract][Full Text] [Related]
15. An NS5A single optimized method to determine genotype, subtype and resistance profiles of Hepatitis C strains.
Andre-Garnier E; Besse B; Rodallec A; Ribeyrol O; Ferre V; Luco C; Le Guen L; Bourgeois N; Gournay J; Billaud E; Raffi F; Coste-Burel M; Imbert-Marcille BM
PLoS One; 2017; 12(7):e0179562. PubMed ID: 28727784
[TBL] [Abstract][Full Text] [Related]
16. The global origins of resistance-associated variants in the non-structural proteins 5A and 5B of the hepatitis C virus.
Jones BR; Howe AYM; Harrigan PR; Joy JB
Virus Evol; 2018 Jan; 4(1):vex041. PubMed ID: 29362671
[TBL] [Abstract][Full Text] [Related]
17. HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection.
Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FM; Hellard ME; Hajarizadeh B; Teutsch S; White B; Maher L; Dore GJ; Lloyd AR; Grebely J; Applegate TL
Infect Genet Evol; 2016 Jan; 37():252-8. PubMed ID: 26631810
[TBL] [Abstract][Full Text] [Related]
18. Ser235 phosphorylation of hepatitis C virus NS5A is required for NS5A dimerization and drug resistance.
Lee WP; Tsai KC; Liao SX; Huang YH; Hou MC; Lan KH
Life Sci; 2024 Jan; 337():122338. PubMed ID: 38072190
[TBL] [Abstract][Full Text] [Related]
19. Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain.
Rivero-Juarez A; Gutierrez-Valencia A; Castaño M; Merino D; Neukam K; Ríos-Villegas MJ; Lopez-Ruz MA; Jiménez-Aguilar P; Marquez M; Collado A; Gomez-Vidal A; Hernandez-Quero J; Tellez F; Fernandez-Fuertes E; Rivero A; López-Cortés LF;
Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2247-55. PubMed ID: 26342330
[TBL] [Abstract][Full Text] [Related]
20. Lasting differential gene expression of circulating CD8 T cells in chronic HCV infection with cirrhosis identifies a role for Hedgehog signaling in cellular hyperfunction.
Li J; Vranjkovic A; Read D; Delaney SP; Stanford WL; Cooper CL; Crawley AM
Front Immunol; 2024; 15():1375485. PubMed ID: 38887299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
